Automera
Empowering the next evolution in degradation platforms.
10 employees · est. 2022 · Singapore, Singapore
Imugene Limited
Bringing Effective New Treatments And Options To Patients Who Need Them
29 employees · est. 2013 · Australia
Imugene Limited is the older company (2022 vs 2013); Imugene Limited is the larger of the two.
Side-by-Side Comparison
| Metric | Automera | Imugene Limited |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2013 older |
| Headquarters | ||
| Headquarters | Singapore, Singapore | Australia |
| Employees | ||
| Employees | 10 | 29 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | IPO |
| Total Funding | ||
| Total Funding | $16.00M | $118.42M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Developing immuno-oncology treatments, Conducting clinical trials for cancer therapies, Research and development of oncolytic viruses, Producing cancer vaccines |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Healthcare providers, Clinical researchers |
| Taxonomy | ||
| Taxonomy | Biotech, Drug Development, Therapeutic Approach, Autophagy, Protein Degradation, Oncology, Cancer, Disease Areas, Quantum Chemistry, AI-enabled Insights, Talo Labs Pte Ltd, Early-stage, AUTAC Platform, Founder-led | Immuno-oncology, Immunotherapy, B-cell Peptide Vaccines, Oncolytic Virotherapy, Cancer Immunotherapy, Tumor Eradication, Cancer Vaccines, Her-2+ Cancers, Immune System Activation, Drug Development, Combination Therapies, Checkpoint Inhibitors, CD19 CAR T-cell Therapy, Immune Checkpoint Inhibitor Monoclonal Antibodies |
| Website | ||
| Website | automeratx.com | imugene.com |
About Automera
Automera is an early-stage biotechnology company founded in 2022 in Singapore. The company's mission is to develop a groundbreaking therapeutic approach through autophagy-based targeted protein degradation. Automera sets itself apart by combining its deep understanding of autophagy with advanced dru...
About Imugene Limited
Imugene Limited, founded in 2013 and headquartered in Australia, is a promising player in the Biotechnology and Health Care industries. The company is advancing novel immuno-oncology therapies aimed at leveraging the body's immune system to combat cancer, which can potentially provide an alternative...
We will tell you when either one moves
BounceWatch watches Automera and Imugene Limited for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Automera and Imugene Limited — by email.
Frequently Asked Questions
Compare Automera with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Automera on 12 Sep 2024, and Imugene Limited on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.